Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p. K3326* Variant in BRCA2

W Kluźniak, A Szymiczek, A Rodrigue… - JCO Precision …, 2022 - ascopubs.org
PURPOSE The BRCA2 p. K3326* variant is considered a low-penetrance variant for breast
cancer. Aldehydes that accumulate in cells under insufficient aldehyde oxidation were most …

Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p. K3326* Variant in BRCA2

W Kluźniak, A Szymiczek, A Rodrigue… - JCO precision …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose The BRCA2 p. K3326* variant is considered a low-penetrance variant for breast
cancer. Aldehydes that accumulate in cells under insufficient aldehyde oxidation were most …

Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p. K3326* Variant in BRCA2

W Kluźniak, A Szymiczek, A Rodrigue… - JCO Precision …, 2022 - ascopubs.org
PURPOSE The BRCA2 p. K3326* variant is considered a low-penetrance variant for breast
cancer. Aldehydes that accumulate in cells under insufficient aldehyde oxidation were most …

Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p. K3326* Variant in BRCA2.

W Kluźniak, A Szymiczek, A Rodrigue… - JCO Precision …, 2022 - europepmc.org
Purpose The BRCA2 p. K3326* variant is considered a low-penetrance variant for breast
cancer. Aldehydes that accumulate in cells under insufficient aldehyde oxidation were most …